Correction Volume 12, Issue 3 pp 3114—3116

Meng Wu^1, , Lingwei Ma^1, , Liru Xue^1, , Wenlei Ye^1, , Zhiyong Lu^2, , Xiang Li^1, , Yan Jin^1, , Xian Qin^1, , Dan Chen^1, , Weicheng Tang^1, , Yingying Chen^1, , Zixin Hong^1, , Jinjin Zhang^1, , Aiyue Luo^1, , Shixuan Wang^1, ,

Received: January 1, 2020       Accepted: January 10, 2020       Published: February 11, 2020      

Copyright: © 2020 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: The authors requested to replace Figure 4E and Figure 6. The mistakes of these figures are described below:

Figure 4E: The authors submitted wrong c-kit in panel E of Figure 4.

Figure 6: The order in panels D and E of Figure 6 was reversed. The H2O2 and the H2O2+Res group in the original Figure 6D of apoptotic analysis was reversed.

These corrections do not change any of the conclusions of the publication. The corrected Figure 4E and Figure 6 are provided below.

Figure 4. Morphology and characteristics of OSCs. (E) Reverse transcription PCR analysis for the expression profile of OSCs using ovarian tissue as a positive control. M: 100 bp DNA marker; No RT, PCR of RNA sample without reverse transcriptase.

Figure 6. Resveratrol attenuated H2O2‐induced cytotoxicity and oxidant stress injury in OSCs. (A) CCK8 assay for treated OSCs;*p < 0.05. (B) Analysis of intracellular ROS by cell flow cytometry. (C) Immunofluorescence staining of γ‐H2AX and Hoechst. Scale bar: 50 μm. (D) The flow cytometry apoptotic analysis of treated OSCs. (E) Western blotting of related protein expression levels in treated OSCs.